Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development

Paul Rhyne from BDS Shares Recommended Multiplexing Techniques

Paul Rhyne, PhD, Chief Scientific Officer at Biologic Development Services (BDS), shares insights from a review article co-authored with 11 colleagues from pharmaceutical companies, clinical research organizations (CRO), and government agencies over two years titled: Recommendations for Use and Fit-for-Purpose Validation of Biomarker Multiplex Ligand Binding Assays in Drug Development.

In this 25-minute webinar, you’ll learn about:

  • The basics of multiplexing plus considerations for the use of planar versus suspension (bead based) arrays
  • Overcoming challenges associated with multiplexing including specificity (cross-reactivity),
  • Validation tips including how to achieve precision, parallelism, and stability
  • What to do if a single analyte fails

Please note: The recording has audio quality issues that resolve at minute five.

About Webinar Wednesday

In 2018, we are presenting a new blog series called Webinar Wednesday. Throughout this series, we will share the diverse work of the xMAP multiplexing community by highlighting webinars from the xMAP Connect users group meetings, live webinars, Luminex field application scientists, and Luminex partners. We hope you enjoy the new series!

Subscribe to the blog to stay on top of all the latest Luminex news.

Webinar Wednesday: Overcome Biomarker Multiplexing Challenges in Drug Development